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Abstract
Background:  Because of its dramatic public health impact, Plasmodium falciparum resistance to
chloroquine (CQ) has been documented early on. Chloroquine-resistance (CQR) emerged in the late
1950's independently in South East Asia and South America and progressively spread over all malaria areas.
CQR was reported in East Africa in the 1970's, and has since invaded the African continent. Many
questions remain about the actual selection and spreading process of CQR parasites, and about the
evolution of the ancestral mutant gene(s) during spreading.
Methods: Eleven clinical isolates of P. falciparum from Cambodia and 238 from Africa (Senegal, Ivory
Coast, Bukina Faso, Mali, Guinea, Togo, Benin, Niger, Congo, Madagascar, Comoros Islands, Tanzania,
Kenya, Mozambique, Cameroun, Gabon) were collected during active case detection surveys carried out
between 1996 and 2001. Parasite DNA was extracted from frozen blood aliquots and amplification of the
gene pfcrt exon 2 (codon 72–76), exon 4 and intron 4 (codon 220 and microsatellite marker) were
performed. All fragments were sequenced.
Results: 124 isolates with a sensitive (c76/c220:CVMNK/A) haplotype and 125 isolates with a resistant
c76/c220:CVIET/S haplotype were found. The microsatellite showed 17 different types in the isolates
carrying the c76/c220:CVMNK/A haplotype while all 125 isolates with a CVIET/S haplotype but two had
a single microsatellite type, namely (TAAA)3(TA)15, whatever the location or time of collection.
Conclusion: Those results are consistent with the migration of a single ancestral pfcrt CQR allele from
Asia to Africa. This is related to the importance of PFCRT in the fitness of P. falciparum point out this
protein as a potential target for developments of new antimalarial drugs.
Published: 26 April 2006
Malaria Journal2006, 5:34 doi:10.1186/1475-2875-5-34
Received: 05 January 2006
Accepted: 26 April 2006
This article is available from: http://www.malariajournal.com/content/5/1/34
© 2006Ariey et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Malaria Journal 2006, 5:34 http://www.malariajournal.com/content/5/1/34
Page 2 of 5
(page number not for citation purposes)
Background
The molecular basis of chloroquine resistance has recently
been elucidated. Pfcrt (Plasmodium falciparum chloroquine
resistance transporter), a single copy, 13-exon gene, local-
ized on chromosome 7, codes for a parasite digestive vac-
uole trans-membrane protein, which plays a key role in
CQR [1,2]. The pfcrt gene appears to be polymorphic and
more than 20 different amino-acid sequences have been
identified [3-5]. Recent genome wide microsatellite scan-
ning has shown marked linkage disequilibrium around
the pfcrt locus and pointed to four distinct founder events,
with one ancestral mutant originating in Asia and subse-
quently invading Africa [6]. The evolution of this mutant
after its local emergence and its spread across Africa has
not been studied.
Specific sets of mutations in pfcrt have been associated
with chloroquine resistance. All but one in vitro CQ-sensi-
tive (CQS) isolates carry a CVMNK haplotype at residues
72–76, whereas in vitro CQR isolates and isolates collected
from CQ treatment failures harbour a different 72–76
haplotype. Strikingly, in spite of numerous studies done
in Africa, only one resistant haplotype (CVIET) has been
ever found so far in this continent. This haplotype carries
in addition to the set of mutations in codons 72–76
within exon 2, a A to S mutation at codon 220 located
within exon 4, resulting in a CVIET/S haplotype [7]. Nine
bp downstream from this mutation starts intron 4, which
contains a polymorphic (TAAA)n(TA)m microsatellite
(Figure 1). Because microsatellites evolve much faster
than coding sequences, intron-associated microsatellite
polymorphism can be used to ear-mark individual pfcrt
alleles and to pin-point the spread of specific alleles. In
order to test the 'one event invasion theory', a characteri-
zation of CVMNK/A and CVIET/S alleles from Asia and
Africa was carried out.
Methods
Sampling
Eleven clinical isolates of P. falciparum from Cambodia,
112 from West and Central Africa (Senegal, Ivory Coast,
Bukina Faso, Mali, Guinea, Togo, Benin, Niger, Congo)
and 126 from East and South Africa (Madagascar,
Comoros Islands, Tanzania, Kenya, Mozambique, Camer-
oun, Gabon) were collected during active case detection
surveys carried out between 1996 and 2001. Briefly, 5 mL
blood samples were collected in EDTA vacutainers from
patients diagnosed as having uncomplicated P. falciparum
malaria. Immediately after blood collection, the patients
were treated according to national recommendations.
Blood samples were kept at 4°C for in vitro drug sensitivity
testing. An aliquot of each isolate was frozen at -20°C for
molecular analysis. Informed consent was obtained from
the patients. Ethical clearance was obtained from the
respective National Ethical Commitees.
DNA extraction, PCR analysis and sequencing
Parasite DNA was extracted from frozen blood aliquots by
the phenol-chloroform method as described previously
[8]. The pfcrt haplotype was determined by sequencing
PCR fragments, amplified from single clone infections (as
determined using msp2 amplification profiles see [8] for
detail) using two sets of primers designed to amplify a 194
bp exon 2 fragment (CRT76-sense 5'-GGTGGAGGTTCTT-
GTCTTGG-3 and CRT76-antisense 5'-ATAAAGTTGT-
GAGTTTCGGATG-3') and 309 bp fragment from exon 4
to exon 5 (CRT220-sense 5'-TTATACAATTATCTCGGAG-
CAG-3' and CRT220-antisense 5'-CATGTTTGAAAAGCAT-
pfcrt genomic sequence available in EMBL Figure 1
pfcrt genomic sequence available in EMBL. In bold, the mutation leading to the amino acid change in 220 position, in italic 
the beginning of the 4th intron of the pfcrt gene showing the (TAAA)m(TA)n microsatellite (underscore).
Strain 3D7 plasmoDB reference MAL7Pl.27
Strain Dd2 AF030694_16
Strain 3D7 TTATTATTGT TGTAACAATA GCTCTTGTAG AAATGAAATT ATCTTTTGAA ACACAAGAAG
Strain Dd2 TTATTATTGT TGTAACAATA GCTCTTGTAG AAATGAAATT ATCTTTTGAA ACACAAGAAG
Strain 3D7 AAAATTCTAT CATATTTAAT CTTGTCTTAA TTAGTGCCTT AATTGTAAGA AAACAAAATA
Strain Dd2 AAAATTCTAT CATATTTAAT CTTGTCTTAA TTAGTTCCTT AATTGTAAGA AAACAAAATA
STrain 3D7 TATAAATAAA TAAATATATA TATATATATA TATATA---- ----TTGTAA TATTTAATAT
Strain Dd2 TATAAATAAA TAAATATATA TATATATATA TATATATATA TATATTGTAA TATTTAATAT
Strain 3D7 phenotype CQS haplotype CVMNK/ A Microsatellite (TAAA)3(TA)11
Strain Dd2 phenotype CQR haplotype CVIET/ S Microsatellite (TAAA)3(TA)15Malaria Journal 2006, 5:34 http://www.malariajournal.com/content/5/1/34
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ACAGGC-3'). The primers were selected on the basis of
the sequence of the pfcrt gene of the Dd2 clone (accession
number AF030694). PCR was performed in a PTC-100
thermal cycler (MJ Research, Merck Eurolab) under the
following conditions: 50 µL final volume containing 2 µL
DNA, 200 µM each dNTP, 0.5 µM each primer, 2 mM
MgCl2, and 2 U TaqI DNA polymerase (Promega) in the
buffer supplied by the manufacturer.
The amplification conditions were: 1 min at 95°C, 1 min
30 at 59°C, and 1 min at 72°C for 1 cycle; 10 s at 95°C, 1
min 30 at 59°C, and 2 min at 72°C for 35 cycles, and a
final extension step at 72°C for 10 min. The resulting PCR
products contained codons 76 and 220 as well as intron
4, respectively. All fragments were subjected to gel electro-
phoresis on agarose gels containing ethidium bromide
and were sequenced using the fluorescent dye terminator
method as described in [9]. The multiple infections still
found on the basis of sequencing of the microsatelittes
were discarded from the analysis (two Cambodian and six
African isolates). Each sequence was analysed using Chro-
mas® v 1.45 software.
Results
Briefly, 124 isolates with a sensitive (CVMNK/A) haplo-
type and 125 isolates with a resistant CVIET/S haplotype
were typed for the intron 4 microsatellite. Polymorphism
of this locus was large, with total of 17 distinct microsat-
ellite alleles identified, namely forteen (TAAA)3 (TA)7-21
and three (TAAA)4 (TA)11-18 (Figure 2). All 17 types
were detected in the isolates carrying the CVMNK/A hap-
lotype. Thus, numerous distinct alleles carry the "wild
type" CQS haplotype. The individual distribution of the
various microsatellite types was consistent with a random
generation of polymorphism, as expected for microsatel-
lites and there were no indication of clustering. In con-
trast, all 125 isolates with a CVIET/S haplotype but two
had a single microsatellite type, namely (TAAA)3(TA)15,
whatever the location or time of collection. The same mic-
rosatellite type was found in the CQR Dd2 clone of the
pfcrt intron 4 microsatellite allelic frequencies in different populations Figure 2
pfcrt intron 4 microsatellite allelic frequencies in different populations. The relative frequency of the various allelic 
forms within each haplotype subgroup is indicated. Number of CVMNK/A isolates investigated was 89 from East and Austral 
Africa and 35 from West and Central Africa. Number of CVIET/S isolates investigated was 37 from East and Austral Africa, 77 
from West and Central Africa and 11 from Cambodia. (TAAA)m(TA)n alleles are classified according to the number (n) of TA 
repeats that follow (TAAA)3 (plain bars) or (TAAA)4 (hatched bars). The colour codes for the various geographical regions 
are blue for East and Austral Africa, red for West and Central Africa and yellow for Cambodia.
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IndochinaIII strain used for the original characterization
of the resistant CVIET/S allele (Figure 1). On the other
hand, the (TAAA)3(TA)11 type of the CQS 3D7 reference
clone was observed in only six of 124 field isolates with
the CVMNK/A haplotype, consistent with the extensive
Pfcrt intron 4 polymorphism in CQS isolates.
The strikingly different microsatellite distribution in iso-
lates carrying a resistant or a sensitive haplotype was
highly significant (chi-square test P < 0.00001). Intron 4
microsatellite field polymorphism is such that the obser-
vation of a single allelic form in all but two isolates carry-
ing a resistant haplotype cannot be explained by chance.
This indicates that the resistant CVIET/S haplotype is
indeed ear-marked by a specific intragenic microsatellite,
and points to the existence of a single progenitor allelic
form for this locus in African areas investigated here. This
represents a strong population genetic evidence for an
absence of endogenous emergence of a resistant allele in
Africa. It demonstrates the migration of one single CVIET/
S pfcrt allele from South East Asia into Africa and its sub-
sequent spreading throughout the whole African conti-
nent.
Discussion
Interestingly, a similar analysis on 15 CQR isolates from
French Guiana showed that the typical South American
(SVMNT/S) resistant haplotype was also associated with a
single (TAAA)3(TA)14 microsatellite type, that differed
from the (TAAA)3(TA)15 observed in African and Asian
CQR isolates. This indicates that the microsatellite
sequence itself has limited phenotypic impact and is rem-
iniscent with the association of resistant pfcrt haplotypes
with specific intron 4 microsatellites. This shows that
resistant haplotypes that have emerged independently in
Asia and in South America more than 30 years ago have
limited local diversity nowadays.
Why did resistant parasites emerge in Asia/America and 
not in Africa, despite the larger size of the overall African 
P. falciparum population?
One of the explanations could be that there is higher P.
falciparum mutation rate in Asia/America than in Africa
[10]. But, if so, after two decades without CQ pressure in
Asia/America, falciparum pfcrt would have "reversed" to
the wild type allele, since the appearance of resistant
strains occurred at the very beginning of the introduction
of chloroquine on a large scale. The latest studies, that
were performed in Asia/America, show no reappearance
of wild type pfcrt strains, invalidate this hypothesis [4].
Most likely, this emergence can be attributed to differ-
ences in transmission conditions and population struc-
ture. The endemic areas in South East Asia and South
America can be considered as "localized permanent epi-
demics" [11], with a metapopulation structure for the P.
falciparum populations, in which forces acting on differen-
tiation are more effective than in Africa [12]. Indeed pop-
ulation isolation is thought to lead to an increased
parasite diversity or local sub-speciation. In a subpopula-
tion of a small number of parasites, genetic drift will act as
a major force. This will increase polymorphism on coding
sequence without any link with the possible fitness of the
selected allele (this also as been shown for cytochrome b
sequence in Asia/America compared to Africa [13]). When
CQ pressure increased, some pfcrt alleles associated with
low fitness in CQ free environment will become associ-
ated with a high fitness in this CQ environment and could
thus invade the African parasite population. If CQ pres-
sure stops, and if the ''wild type allele" is still present in
the subpopulation, it will replace the mutant allele (stud-
ies in Malawi show that the relative fitness of the mutant
pfcrt allele in the absence of CQ pressure is 0.76 or 0.86
[15,16]).
Conclusion
Field isolates collected from clinical cases confirm that the
current continent-wide CQR in Africa is due to the inva-
sion of a single mutant allele. Therefore, monitoring the
gene flow regionally can provide valuable information in
assessing selection of candidate resistance gene by selec-
tive drug pressure for other antimalarials or vaccine
escape.
Moreover, despite the overall PfCRT protein polymor-
phisms described so far in Asia [4], only one major allele
has invaded Africa. This can probably be explain by the
importance of this protein in the fitness of the parasite
and thus to the difficulty for a pfcrt mutant to be selected
in CQ-free area of high transmission where fierce compe-
tition occurs between strains. This strongly suggest that
pfcrt is still one of the major potential target for antimalar-
ial drugs and reinforces the need for a better understand-
ing of its role in Plasmodium metabolism [17].
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
FA, TF, RD, MR, RJ, EL, JBD, VR, JLB and OMP paritcipate
to the sampling, the molecular typing of isolates, the data
analysis and contributed for the elaboration of manu-
script. MTE, CB and SC performed the molecular analysis
of the majority of the samples. All authors read and
approved the final manuscript.
Acknowledgements
This work was funded by the French Academy of Sciences and the FSP-RAI 
project from the French government. We are indebted to the field workers Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Malaria Journal 2006, 5:34 http://www.malariajournal.com/content/5/1/34
Page 5 of 5
(page number not for citation purposes)
(physicians, nurses and technicians) for participation in collecting parasit-
ized blood samples.
References
1. May J, Meyer CG: Chemoresistance in falciparum malaria.
Trends Parasitol 2003, 19:432-435.
2. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig
MT, Ursos LM, Sidhu AB, Naude B, Deitsch KW, Su XZ, Wootton JC,
Roepe PD, Wellems TE: Mutations in the P. falciparum digestive
vacuole transmembrane protein PfCRT and evidence for
their role in chloroquine resistance.  Mol Cell 2000, 6:861-871.
3. Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, Magill
AJ, Su XZ: Genetic diversity and chloroquine selective sweeps
in Plasmodium falciparum.  Nature 2002, 418:320-323.
4. Lim P, Chy S, Ariey F, Incardona S, Chim P, Sem R, Denis MB, Hewitt
S, Hoyer S, Socheat D, Merecreau-Puijalon O, Fandeur T: pfcrt pol-
ymorphism and chloroquine resistance in Plasmodium falci-
parum strains isolated in Cambodia.  Antimicrob Agents Chemother
2003, 47:87-94.
5. Uhleman AC, Yuthavong Y, Fidock DA: Mechanisms of antimalar-
ial drug action and resistance.  In Molecular approaches to malaria
Edited by: Sherman IW. Washington DC. ASM Press; 2005:429-461. 
6. Mehlotra RK, Fujioka H, Roepe PD, Janneh O, Ursos LM, Jacobs-
Lorena V, McNamara DT, Bockarie MJ, Kazura JW, Kyle DE, Fidock
DA, Zimmerman PA: Evolution of a unique Plasmodium falci-
parum chloroquine-resistance phenotype in association with
pfcrt polymorphism in Papua New Guinea and South Amer-
ica.  Proc Natl Acad Sci U S A 2001, 98:12689-12694.
7. Waller Karena L, Lee Sylvia, Fidock David A: Molecular and Cellu-
lar Biology of Chloroquine Resistance in Plasmodium falci-
parum.  Genomes and Molecular Biology 2004, Chapter 16:.
8. Contamin H, Fandeur T, Bonnefoy S, Skouri F, Ntoumi F, Mercereau-
Puijalon O: PCR typing of field isolates of Plasmodium falci-
parum.  J Clin Microbiol 1995, 33:944-951.
9. Ariey F, Randrianarivelojosia M, Duchemin JB, Rakotondramarina D,
Ouledi A, Robert V, Jambou R, Jahevitra M, Andrianantenaina H,
Raharimalala L, Mauclere P: Mapping of a Plasmodium falciparum
pfcrtK76T mutation: a useful strategy for controlling chloro-
quineresistance in Madagascar.  J Infect Dis 2002, 185:710-712.
10. Rathod PK, McErlean T, Lee PC: Variations in frequencies of
drug resistance in Plasmodium falciparum.  Proc Natl Acad Sci U
S A 1997, 94:9389-9393.
11. Verdrager J: Localized permanent epidemics: the genesis of
chloroquine resistance in Plasmodium falciparum.  Southeast
Asian J Trop Med Public Health 1995, 26:23-28.
12. Ariey F, Duchemin JB, Robert V: Metapopulation concepts
applied to falciparum malaria and their impacts on the
emergence and spread of chloroquine resistance.  Infect Genet
Evol 2003, 2:185-192.
13. Ekala M, Legrand E, Kim N, Randrianarivelojosia M, Jambou R, Fan-
deur T, Ariey F, Bouchier C, Mercereau Puijalon O: Sequencevari-
ations of Plasmodium falciparum cytochrome b in field
isolates from a multicentric study.  Abstract MIM-ME-142462
Yaounde Cameroun 2005.
14. Mita T, Kaneko A, Lum JK, Zungu IL, Tsukahara T, Eto H, Kobayakawa
T, Bjorkman A, Tanabe K: Expansion of wild type allele rather
than back mutation in pfcrt explains the recent recovery of
chloroquine sensitivity of Plasmodium falciparum in Malawi.
Mol Biochem Parasitol 2004, 135:159-163.
15. Kublin JG, Cortese JF, Njunju EM, Mukadam RA, Wirima JJ, Kazembe
PN, Djimde AA, Kouriba B, Taylor TE, Plowe CV: Reemergence
ofchloroquine-sensitive Plasmodium falciparum malaria after-
cessation of chloroquine use in Malawi.  J Infect Dis 2003,
187:1870-1875.
16. Cortese JF, Caraballo A, Contreras CE, Plowe CV: Origin and dis-
semination of Plasmodium falciparum drug-resistance muta-
tions in South America.  J Infect Dis 2002, 186:999-1006.
17. Cooper RA, Hartwig CL, Ferdig MT: pfcrt is morethan the Plas-
modium falciparum chloroquine resistance gene: a functional
and evolutionary perspective.  Acta Trop 2005, 94:170-180.